BioXcel Therapeutics Inc (BTAI) Stock Price, Quote, News & History

BTAINASDAQ
$1.19
N/A
At close: Jun 2, 5:00 PM EST
$1.17
-0.0181-1.52%
After Hours: 5:49 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-57.38M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
43.55M
Free Cash Flow (TTM)
-57.38M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-13.83M

Analyst Trends and Forecast

2
Mar
1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$120.01M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
29.69
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-399.16%
Earnings Yield % (FWD)
-117.57%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$3.42

Company Debt

Total Debt
$100.29M
LT Debt
$77.86M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$8.11M
Total Cash
$17.18M
Debt to Equity
-
Issuance of Debt (TTM)
-$8.11M
Repayment of Debt (TTM)
-$8.11M

Key Statistics

Open
$1.19
Close
$1.19
Volume / Avg.
531.93K / 1.59M
Day Range
$1.16 - $1.25
52 Wk Range
1.01 - 8.08
Market Cap
$36.19M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
48
Short Interest
11.73%
Days to Cover
5.66

About

Sector
Health Care
Industry
Biotechnology
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeli...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BioXcel Therapeutics (BTAI) stock?

A

You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BioXcel Therapeutics (BTAI) competitors?

A

There are no as such competitors for BioXcel Therapeutics.

Q

What is the forecast, or price target, for BioXcel Therapeutics (BTAI) stock?

A

BioXcel Therapeutics has a consensus price target of $18.58.

Q

What is the current price for BioXcel Therapeutics (BTAI)?

A

The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $1.1719 last updated June 2, 2026 at 5:49 PM EDT.

Q

Does BioXcel Therapeutics (BTAI) pay a dividend?

A

There are no upcoming dividends for BioXcel Therapeutics.

Q

When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?

A

BioXcel Therapeutics does not have any upcoming earnings scheduled.

Q

Is BioXcel Therapeutics (BTAI) going to split?

A

There is no upcoming split for BioXcel Therapeutics.

Q

What sector and industry does BioXcel Therapeutics (BTAI) operate in?

A

BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.